Innonix Technologies Limited
Innonix Technologies Limited has passed strict NIOSH certification and tested to be effective against 18 types of Flu Viruses, surrogates of SARS, MERS, and other pathogens. Innonix Technologies (HK) Limited is a biotechnology innovation powerhouse that develops disruptive technologies and products to address unmet health needs in medical, consumer, industrial, and government/military markets around the world.
RESPOKARE N95 mask RK-200 series is NIOSH-approved and CDC-approved (approval number 84A-7796) particulate respirators designed to be effective against particulate aerosols free of oil with a 95% filter efficiency level. This revolutionary patented advanced antiviral technology is the first FDA cleared Anti-Viral face mask based on inactivation of influenza viruses and under a new product category OUK (Surgical Mask With Antimicrobial/Antiviral Agent). Not only blocks 95% of small (.3 micron) particles but inactivates up to 99.9% within minutes.
Case, Sample-one box